The Community Guide

- gsearch

Search Results

Narrow Results:

2024 1
2023 1
2017 1
2016 1
2013 1

National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.)Division of Tuberculosis Elimination. 1

Colorado 1

Journal Article 5

1 - 5 of 5 Results

Refine Results

Refine Results:

High Rate of Treatment Completion in Program Settings with 12-Dose Weekly Isoniazid and Rifapentine (3HP) for Latent Mycobacterium tuberculosis Infection

CITE Title : High Rate of Treatment Completion in Program Settings with 12-Dose Weekly Isoniazid and Rifapentine (3HP) for Latent Mycobacterium tuberculosis Infection Personal Author(s) : Sandul, Amy L.;Nwana, Nwabunie;Holcombe, J. Mike;Lobato, Mark N.;Marks, Suzanne;Webb, Risa;Wang, Shu-Hua;Stewart, Brock;Griffin, Phil;Hunt, Garrett;Shah, Neha;Marco, Asween;Patil, Naveen;Mukasa, Leonard;Moro, Ruth N.;Jereb, John;Mase, Sundari;Chorba, Terence;Bamrah-Morris, Sapna;Ho, Christine S.; Published Date : Oct 01 2017 Source : Clin Infect Dis. 65(7):1085-1093. URL : https://stacks.cdc.gov/view/cdc/50422 Sandul, Amy L. et al. (2017). High Rate of Treatment Completion in Program Settings with 12-Dose Weekly Isoniazid and Rifapentine (3HP) for Latent Mycobacterium tuberculosis Infection. 65(7). Sandul, Amy L. et al. "High Rate of Treatment Completion in Program Settings with 12-Dose Weekly Isoniazid and Rifapentine (3HP) for Latent Mycobacterium tuberculosis Infection" 65, no. 7 (2017) Sandul, Amy L. et al. "High Rate of Treatment Completion in Program Settings with 12-Dose Weekly Isoniazid and Rifapentine (3HP) for Latent Mycobacterium tuberculosis Infection" vol. 65, no. 7, 2017 Export RIS Citation Information.

:

Sandul, Amy L. ;

Nwana, Nwabunie

Oct 01 2017 | Clin Infect Dis. 65(7):1085-1093.

:

BackgroundRCTs demonstrated the newest LTBI regimen, 12 weekly doses of directly observed isoniazid and rifapentine (3HP), as efficacious as 9 months ...
Examining Test Cutoffs to Optimize Diagnosis of Latent Tuberculosis Infection in People Born Outside the United States

CITE Title : Examining Test Cutoffs to Optimize Diagnosis of Latent Tuberculosis Infection in People Born Outside the United States Personal Author(s) : Zavala, Sofia;Winglee, Kathryn;Ho, Christine S.;Pettit, April C.;Ahmed, Amina;Katz, Dolly J.;Belknap, Robert W.;Stout, Jason E.; Published Date : 9 2023;9-2023; Source : Ann Am Thorac Soc. 20(9):1258-1266 URL : https://stacks.cdc.gov/view/cdc/151713 Zavala, Sofia et al. (2023). Examining Test Cutoffs to Optimize Diagnosis of Latent Tuberculosis Infection in People Born Outside the United States. 20(9). Zavala, Sofia et al. "Examining Test Cutoffs to Optimize Diagnosis of Latent Tuberculosis Infection in People Born Outside the United States" 20, no. 9 (2023) Zavala, Sofia et al. "Examining Test Cutoffs to Optimize Diagnosis of Latent Tuberculosis Infection in People Born Outside the United States" vol. 20, no. 9, 2023 Export RIS Citation Information.

:

Zavala, Sofia

;

Winglee, Kathryn

9 2023 | Ann Am Thorac Soc. 20(9):1258-1266

:

Rationale:Detection of latent tuberculosis infection (LTBI) in persons born in high tuberculosis (TB) incidence countries living in low TB incidence c...
Interferon-Gamma Release Assays and Pediatric Public Health Tuberculosis Screening: The San Francisco Program Experience 2005 to 2008

CITE Title : Interferon-Gamma Release Assays and Pediatric Public Health Tuberculosis Screening: The San Francisco Program Experience 2005 to 2008 Personal Author(s) : Grinsdale, Jennifer A.;Islam, Shamim;Tran, Olivia Chang;Ho, Christine S.;Kawamura, L. Masae;Higashi, Julie M.; Published Date : 6 2016;6-2016; Source : J Pediatric Infect Dis Soc. 5(2):122-130 URL : https://stacks.cdc.gov/view/cdc/119211 Grinsdale, Jennifer A. et al. (2016). Interferon-Gamma Release Assays and Pediatric Public Health Tuberculosis Screening: The San Francisco Program Experience 2005 to 2008. 5(2). Grinsdale, Jennifer A. et al. "Interferon-Gamma Release Assays and Pediatric Public Health Tuberculosis Screening: The San Francisco Program Experience 2005 to 2008" 5, no. 2 (2016) Grinsdale, Jennifer A. et al. "Interferon-Gamma Release Assays and Pediatric Public Health Tuberculosis Screening: The San Francisco Program Experience 2005 to 2008" vol. 5, no. 2, 2016 Export RIS Citation Information.

:

Grinsdale, Jennifer A. ;

Islam, Shamim

6 2016 | J Pediatric Infect Dis Soc. 5(2):122-130

:

Background.Interferon-gamma release assay utilization in pediatric tuberculosis (TB) screening is limited by a paucity of longitudinal experience, par...
Test and treat approach for tuberculosis infection amongst household contacts of drug-susceptible pulmonary tuberculosis, Mumbai, India

CITE Title : Test and treat approach for tuberculosis infection amongst household contacts of drug-susceptible pulmonary tuberculosis, Mumbai, India Personal Author(s) : Shah, Daksha;Bhide, Sampada;Deshmukh, Rajesh;Smith, Jonathan P.;Kaiplyawar, Satish;Puri, Varsha;Yeldandi, Vijay;Date, Anand;Nyendak, Melissa;Ho, Christine S.;Moonan, Patrick K.; Published Date : 2024;2024; Source : Front Tuberc. 2 URL : https://stacks.cdc.gov/view/cdc/166678 Shah, Daksha et al. (2024). Test and treat approach for tuberculosis infection amongst household contacts of drug-susceptible pulmonary tuberculosis, Mumbai, India. 2 Shah, Daksha et al. "Test and treat approach for tuberculosis infection amongst household contacts of drug-susceptible pulmonary tuberculosis, Mumbai, India" 2 (2024) Shah, Daksha et al. "Test and treat approach for tuberculosis infection amongst household contacts of drug-susceptible pulmonary tuberculosis, Mumbai, India" vol. 2, 2024 Export RIS Citation Information.

:

Shah, Daksha ;

Bhide, Sampada

2024 | Front Tuberc. 2

:

Background:Mumbai is one of the most densely populated areas in the world and is a major contributor to the tuberculosis (TB) epidemic in India. A tes...
Transmission of Mycobacterium Tuberculosis in a High School and School-Based Supervision of an Isoniazid-Rifapentine Regimen for Preventing Tuberculosis — Colorado, 2011–2012

CITE Title : Transmission of Mycobacterium Tuberculosis in a High School and School-Based Supervision of an Isoniazid-Rifapentine Regimen for Preventing Tuberculosis — Colorado, 2011–2012 Personal Author(s) : Bargman, Carolyn;Reves, Randall;Parker, Matt;Belknap, Robert;Bettridge, Juli;Bedell, Deborah T.;Galvis, Maria E.;Ho, Christine S.;Jereb, John A.; Corporate Authors(s) : National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (U.S.)Division of Tuberculosis Elimination. Published Date : Oct 04 2013 Pages in Document : 5 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR Morbidity Mortal Weekly Rep. 2013; 62(39):805-809. URL : https://stacks.cdc.gov/view/cdc/54735 Journal Title : Morbidity and Mortality Weekly Report (MMWR) Bargman, Carolyn et al. (2013). Transmission of Mycobacterium Tuberculosis in a High School and School-Based Supervision of an Isoniazid-Rifapentine Regimen for Preventing Tuberculosis — Colorado, 2011–2012. 62(39). Bargman, Carolyn et al. "Transmission of Mycobacterium Tuberculosis in a High School and School-Based Supervision of an Isoniazid-Rifapentine Regimen for Preventing Tuberculosis — Colorado, 2011–2012" 62, no. 39 (2013) Bargman, Carolyn et al. "Transmission of Mycobacterium Tuberculosis in a High School and School-Based Supervision of an Isoniazid-Rifapentine Regimen for Preventing Tuberculosis — Colorado, 2011–2012" vol. 62, no. 39, 2013 Export RIS Citation Information.

:

Bargman, Carolyn ;

Reves, Randall

Oct 04 2013 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

Mycobacterium Tuberculosis, the bacterium that causes Tuberculosis (TB), is spread from person to person by the airborne route. It can be transmitted ...